Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-6 sequence variants are not associated with prostate cancer risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 2004

Sun Jielin, Hedelin Maria, Zheng S Lilly, Adami Hans-Olov, Bensen Jeanette, Augustsson-Bälter Katarina, Chang Baoli, Adolfsson Jan, Adams Tamara, Turner Aubrey, Meyers Deborah A, Isaacs William B, Xu Jianfeng, Grönberg Henrik

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Case-Control Studies
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Interleukin-6

Share to Prostatic Neoplasms

Share to Risk Factors

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 15466986

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-6 sequence variants are not associated with prostate cancer risk.PMID 15466986Read ↗

TGFBR1*6A is not associated with prostate cancer in men of European ancestry.Semantic proximity Read ↗

Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer.Semantic proximity Read ↗

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.Semantic proximity Read ↗

No major association between TGFBR1*6A and prostate cancer.Semantic proximity Read ↗

-174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race.Semantic proximity Read ↗

The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.Semantic proximity Read ↗

Interleukin-6 promoter variants, prostate cancer risk, and survival.Semantic proximity Read ↗

MIC1 and IL1RN genetic variation and advanced prostate cancer risk.Semantic proximity Read ↗

Interleukin-6 polymorphism and prostate cancer risk in population of Eastern Croatia.Semantic proximity Read ↗

Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: A population-based studySemantic proximity Read ↗

Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.